Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Boston's CEO (chief executive officer) fights back with attack on Medinol

This article was originally published in Clinica

Executive Summary

Jim Tobin, CEO of Boston Scientific and the centre of accusations by Israeli stent maker Medinol that he revealed to Medinol a secret plot by Boston's previous management to sideline Medinol by starting its own stent manufacturing, has hit back with a stinging attack on Medinol.

Topics

UsernamePublicRestriction

Register

MT070854

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel